Back to User profile » Dr Zhongguo Zhou

Papers published by Dr Zhongguo Zhou:


Efficacy and Safety of Conversion Surgery for Advanced Hepatocellular Carcinoma After Hepatic Arterial Infusion Chemotherapy

Li W, Zheng Z, Wang J, Wu T, Wang J, Pan Y, Chen J, Hu D, Xu L, Zhang Y, Chen M, Zhou Z

Journal of Hepatocellular Carcinoma 2024, 11:463-475

Published Date: 4 March 2024

Systemic Inflammation Score Using Pretherapeutic Inflammatory Markers to Predict Prognosis for Hepatocellular Carcinoma Patients After Hepatic Arterial Infusion Chemotherapy

Wu T, Zheng Z, Wang J, He M, Wang J, Pan Y, Chen J, Hu D, Zhang Y, Xu L, Chen M, Zhou Z

Journal of Hepatocellular Carcinoma 2023, 10:2133-2145

Published Date: 1 December 2023

Tenofovir versus Entecavir on Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma After FOLFOX-Hepatic Arterial Infusion Chemotherapy

Zheng Z, Wang J, Wu T, He M, Wang J, Pan Y, Chen J, Hu D, Xu L, Zhang Y, Chen M, Zhou Z

Journal of Hepatocellular Carcinoma 2023, 10:2117-2132

Published Date: 30 November 2023

A Systemic Inflammation Response Score for Prognostic Prediction in Hepatocellular Carcinoma Patients After Hepatectomy

Zhang D, Huo L, Pan Y, Yang Z, Zeng H, Wang X, Chen J, Wang J, Zhang Y, Zhou Z, Chen M, Hu D

Journal of Inflammation Research 2022, 15:6869-6881

Published Date: 29 December 2022

Inflammation-Based Scores Predict Responses to PD-1 Inhibitor Treatment in Intrahepatic Cholangiocarcinoma

Yang Z, Zhang D, Zeng H, Fu Y, Hu Z, Pan Y, Chen J, Wang J, Zhang Y, Zhou Z, Xu L, Hu D, Chen M

Journal of Inflammation Research 2022, 15:5721-5731

Published Date: 6 October 2022

Hepatic Arterial Infusion Chemotherapy as a Timing Strategy for Conversion Surgery to Treat Hepatocellular Carcinoma: A Single-Center Real-World Study

Wang J, Zheng Z, Wu T, Li W, Wang J, Pan Y, Peng W, Hu D, Hou J, Xu L, Zhang Y, Chen M, Zhang R, Zhou Z

Journal of Hepatocellular Carcinoma 2022, 9:999-1010

Published Date: 14 September 2022

Baseline HBV Loads Do Not Affect the Prognosis of Patients with Hepatocellular Carcinoma Receiving Anti-Programmed Cell Death-1 Immunotherapy

Sun X, Hu D, Yang Z, Liu Z, Wang J, Chen J, Xu L, Zhou Z, Chen M, Zhang Y

Journal of Hepatocellular Carcinoma 2020, 7:337-345

Published Date: 1 December 2020

The mutation of hepatitis B virus and the prognosis of hepatocellular carcinoma after surgery: a pilot study

Zhang Y, Huang J, Chen J, Yang K, Chen J, Xu L, Zhou Z, Chen M

Cancer Management and Research 2018, 10:599-611

Published Date: 27 March 2018